Moderna Inc. said on Thursday it has agreed to push back some COVID-19 vaccine deliveries to the European Union by several months to later in 2022 or early next year.
Shares of Moderna fell nearly 2 percent before the bell over the delay, even though the company stuck to its vaccine sales forecast of $21 billion for 2022.
Delivery of the doses were originally planned in the second quarter, the European Commission said in a statement.
The bloc had also tweaked agreements with Pfizer Inc. and German partner BioNTech SE. in April to delay vaccine deliveries by three months as it gears up for a potential booster campaign in the fall….